Corporate Labyrinth: Delhi High Court’s Forensic Audit Mandate Escalates the High-Stakes Legal Reckoning in the Daiichi-Singh and Fortis-IHH Litigation
Unpacking Cross-Border Arbitral Enforcement, Corporate Governance Failures, and Institutional Lender Accountability Under Indian Law
A Comprehensive Judicial Autopsy of Multi-Million-Dollar Share Transfers, Trust Restructuring, and Contempt Proceedings Involving Fortis Healthcare
By Legal Editor
New Delhi: August 31, 2026:
The intersection of cross-border arbitration, corporate restructuring, and asset-shielding mechanisms has reached a defining milestone in Indian corporate jurisprudence. In a decisive legal development, the Delhi High Court ordered the appointment of a forensic auditor to meticulously examine a complex web of financial transactions involving Fortis Healthcare Limited (FHL), Malaysia’s IHH Healthcare Berhad, and Singapore’s RHT Health Trust. This judicial intervention stems directly from the protracted, high-stakes enforcement proceedings initiated by Japanese pharmaceutical giant Daiichi Sankyo Company Limited. Daiichi is doggedly pursuing the enforcement of a massive international arbitration award secured against former billionaire promoters Malvinder Singh and Shivinder Singh. Valued upwards of $4.6 billion or approximately Rs 3,500 to 5,200 crore when factoring in accrued interest, damages, and legal costs over nearly two decades, this legal battle stands as one of the most convoluted corporate litigations in Indian legal history.
The genesis of this multifaceted dispute dates to 2008, when Daiichi Sankyo acquired a majority 34.82 percent stake in Ranbaxy Laboratories Limited from the Singh brothers for $2.4 billion. Shortly after the acquisition concluded, revelations surfaced regarding serious, undisclosed regulatory investigations by the United States Food and Drug Administration (US FDA) and the United States Department of Justice into Ranbaxy’s manufacturing plants, data integrity protocols, and compliance history. Claiming that the Singh brothers had fraudulently concealed these material regulatory probes during the transaction negotiations, Daiichi initiated arbitration proceedings before a Singapore tribunal under the UNCITRAL rules. In 2016, the tribunal ruled decisively in favor of the Japanese drugmaker, awarding substantial damages on the legal grounds of fraudulent misrepresentation and active concealment of material facts. Since then, Daiichi has faced formidable hurdles in translating this foreign arbitral award into realized recovery within Indian jurisdiction, leading to an expansive web of execution petitions, contempt proceedings, corporate investigations, and multi-jurisdictional asset-tracing applications across global financial centers.
At the heart of the current judicial scrutiny ordered by the Delhi High Court is a critical examination of how the Singh brothers’ erstwhile controlling stake in Fortis Healthcare was progressively diluted, restructured, and transferred. Following the arbitral award, Indian courts issued stringent asset-freeze orders and interim injunctions prohibiting the erstwhile promoters from alienating, encumbering, or transferring their personal assets and corporate shareholdings. However, subsequent investigative filings and judicial observations revealed that millions of shares held by Fortis Healthcare Holding Private Limited and allied entities were pledged to various banks and financial institutions, subsequently invoked, and liquidated. Daiichi argued before the courts that these share pledges and subsequent invocation actions were executed in direct violation of judicial undertakings and specific court directives. Furthermore, the litigation expanded to scrutinize the 2018 corporate transaction wherein Malaysia’s IHH Healthcare acquired a 31 percent controlling stake in Fortis Healthcare for Rs 4,000 crore through a competitive bidding process, as well as complex financial arrangements involving Singapore’s RHT Health Trust, which allegedly absorbed substantial capital transfers amounting to Rs 4,666 crore.
The legal architecture governing this dispute invokes several foundational statutes and intricate statutory principles under Indian law. Primarily, the enforcement mechanism is anchored in Part II of the Arbitration and Conciliation Act, 1996, which governs the enforcement of foreign arbitral awards under the New York Convention. Under Section 48 and Section 49 of the Act, a foreign award is enforceable as a decree of the court once the court is satisfied that the award does not violate the public policy of India or fundamental notions of justice. However, when judgment debtors actively engage in corporate restructuring, asset stripping, or fraudulent conveyances to frustrate execution, Indian courts frequently invoke broader equitable powers alongside statutory enforcement provisions. The statutory framework of Section 48(2)(b) is frequently tested in such multi-jurisdictional awards, where domestic courts must balance international comity, pro-enforcement bias, and domestic creditor protection against egregious fraudulent conduct by award debtors.
Parallelly, the contempt jurisdiction exercised by the Supreme Court of India forms a critical pillar of this litigation. In September 2022, the Supreme Court found Malvinder and Shivinder Singh guilty of civil and criminal contempt for willful disobedience of court orders that explicitly forbade the encumbrance or alienation of Fortis shares. The apex court sentenced the brothers to six months in rigorous imprisonment and remanded the matter back to the Delhi High Court with explicit directions to evaluate the necessity of appointing forensic auditors. The legal basis for contempt is grounded in Section 2(b) and Section 12 of the Contempt of Courts Act, 1971, which empowers superior courts to punish willful breaches of undertaking or court orders to maintain the sanctity and majesty of the judicial process. Furthermore, the invocation of Article 142 of the Constitution of India allows the Supreme Court to pass any decree or order necessary for doing complete justice in any cause or matter pending before it, bypassing rigid procedural roadblocks.
Furthermore, the forensic audit ordered by the High Court brings corporate governance and regulatory compliance statutes into sharp focus, particularly the Companies Act, 2013, and the Securities and Exchange Board of India (SEBI) Act, 1992. SEBI had previously investigated the diversion of approximately Rs 403 crore from Fortis Healthcare for the ultimate benefit of RHC Holding Private Limited, the parent entity controlled by the Singh brothers. Under Sections 11 and 11B of the SEBI Act, the market regulator possesses wide-ranging powers to protect investor interests, regulate securities markets, and issue disgorgement orders against fraudulent promoters who misappropriate listed entity funds. Section 166 of the Companies Act, 2013, outlines the statutory duties of directors, mandating that a director must act in good faith in order to promote the objects of the company for the benefit of its members as a whole, and exercise due and reasonable care. The forensic audit will examine whether the erstwhile promoters and associated managerial personnel breached these statutory fiduciary duties by executing transactions that siphoned value away from Fortis Healthcare, while also examining potential violations under the Prevention of Money Laundering Act where applicable.
Another intensely contested dimension of the Delhi High Court proceedings involves the conduct of seventeen banks and financial institutions, including prominent entities such as HDFC Limited, Yes Bank, Axis Bank, Citicorp Finance, Aditya Birla Sun Life Insurance Company, and Kotak Mahindra Investments. Daiichi Sankyo filed specific applications seeking independent forensic examination of these lenders, alleging that they invoked share pledges and liquidated Fortis shares with full institutional awareness of existing court injunctions and Supreme Court orders. The legal contention hinges on whether these financial institutions acted as bona fide third-party encumbrancers for value without notice, or whether their lending practices and pledge invocations constituted collusive or negligent actions designed to bypass judicial embargoes. Under the Transfer of Property Act, 1882, and contract law principles governing bailment and pledge (Sections 172 to 181 of the Indian Contract Act, 1872), a pawnee possesses statutory rights to sell pledged goods upon default, but this right is severely curtailed when court orders freeze the underlying assets or when lending practices fail basic due diligence standards regarding loss-making borrower entities.
The Supreme Court’s landmark observations in September 2022 specifically mandated that the forensic auditors must scrutinize whether the transactions entered into by these financial institutions were genuinely bona fide and commercially sound, or whether they served as conduits to siphon value away from the reach of the arbitral award. By expanding the forensic mandate to cover transactions between Fortis Healthcare, RHT Health Trust, and the Religare Group entities (including Religare Enterprises, Religare Finvest, Religare Comtrade, and Religare Capital Market), the judiciary aims to construct a comprehensive financial ledger that maps every rupee diverted from the healthcare enterprise. This exhaustive accounting is deemed essential by legal experts to ensure that adequate funds are unmasked and brought back within the execution jurisdiction of the court to satisfy Daiichi’s multi-billion-dollar claim.
Legal practitioners emphasize that forensic audits ordered under judicial supervision carry immense evidentiary weight in execution proceedings. When supervised by retired high court judges or independent chartered accountant firms, these forensic reports provide the empirical foundation required by execution courts to issue consequential attachment and recovery orders against third parties. By systematically unmasking the trail of capital movements across domestic and international holding entities, the audit bridges the evidentiary gap created by sophisticated corporate concealment.
As the forensic auditors commence their examination under the supervision of the Delhi High Court, the broader implications for Indian corporate law are profound. The proceedings serve as a rigorous stress test for the efficacy of cross-border arbitration enforcement, demonstrating that Indian courts will pierce through elaborate corporate veils, inter-corporate loans, and trust structures to unearth hidden assets. Furthermore, the judicial scrutiny of institutional lenders establishes a vital precedent: financial institutions cannot take refuge behind standard commercial pledge invocations when dealing with assets encumbered by judicial embargoes. Ultimately, this judicial rigor reinforces investor confidence by signalling that corporate malfeasance, fraudulent misrepresentations, and asset-shielding manoeuvres will be met with uncompromising accountability under Indian jurisprudence.
Frequently Asked Questions (Searchable Index)
Q1: What prompted the Delhi High Court to order a forensic audit in the Daiichi-Singh case?
Answer: The Delhi High Court ordered the forensic audit pursuant to explicit directions issued by the Supreme Court of India on September 22, 2022. The audit is designed to scrutinize complex financial transactions, share dilution, asset transfers, and corporate restructuring involving Fortis Healthcare Limited, Malaysia’s IHH Healthcare, and Singapore’s RHT Health Trust, ensuring that assets are traceable for the enforcement of Daiichi Sankyo’s $4.6-billion arbitration award.
Q2: What is the origin of the dispute between Daiichi Sankyo and the Singh brothers?
Answer: The dispute originated from Daiichi Sankyo’s 2008 acquisition of a 34.82% controlling stake in Ranbaxy Laboratories Limited from Malvinder Singh and Shivinder Singh for $2.4 billion. Daiichi subsequently discovered that the Singh brothers had fraudulently concealed active US FDA and Department of Justice regulatory investigations into Ranbaxy’s manufacturing and compliance standards. This led to a 2016 Singapore arbitration award of approximately Rs 3,500 to 3,600 crore in favor of Daiichi for fraudulent misrepresentation and active concealment.
Q3: How are banks and financial institutions implicated in these forensic proceedings?
Answer: Daiichi Sankyo filed applications against seventeen banks and financial institutions (including Yes Bank, Axis Bank, HDFC Ltd, and Kotak Mahindra) alleging that they invoked and liquidated pledged shares of Fortis Healthcare in direct violation of court-ordered asset freezes and judicial undertakings. The forensic audit will examine whether these financial institutions engaged in bona fide commercial lending or participated in transactions lacking due diligence to bypass judicial embargoes.
Q4: What role do RHT Health Trust and IHH Healthcare play in the ongoing litigation?
Answer: IHH Healthcare acquired a 31% controlling stake in Fortis Healthcare for Rs 4,000 crore in July 2018 through a competitive bidding process. Simultaneously, Daiichi has alleged a clandestine transfer of Rs 4,666 crore to Singapore-based RHT Health Trust. The forensic audit will examine the exact nature of these cross-border corporate transactions, shareholding dilutions, and inter-corporate fund movements between Fortis and RHT.
Q5: Which key legal statutes and acts govern this multi-layered litigation in India?
Answer: The core legal frameworks governing this multi-layered dispute include Part II of the Arbitration and Conciliation Act, 1996 (governing foreign arbitral award enforcement under Sections 48 and 49), the Contempt of Courts Act, 1971 (under which the Singh brothers were sentenced to six months imprisonment for violating asset-freeze orders), the SEBI Act, 1992 (addressing corporate fund diversion, investor protection, and market regulations), the Companies Act, 2013 (governing directorial fiduciary duties under Section 166 and corporate accountability), the Transfer of Property Act, 1882 (concerning fraudulent transfers), and the Indian Contract Act, 1872 (governing share pledges and bailment under Sections 172 through 181).
Q6: What is the legal significance of the Supreme Court’s September 2022 ruling in this case?
Answer: In September 2022, the Supreme Court found Malvinder and Shivinder Singh guilty of contempt, awarded them six months imprisonment, and directed the Delhi High Court to evaluate appointing forensic auditors. The ruling established that superior courts possess equitable jurisdiction under constitutional powers, including Article 142, to pierce corporate veils, examine whether institutional lender transactions were bona fide, and trace assets siphoned away from execution reach, reinforcing the principle that judicial orders cannot be circumvented through complex corporate layering.
Q7: What is the ultimate objective of the forensic audit supervised by the Delhi High Court?
Answer: The ultimate objective is to trace the movement of funds and assets, uncover any hidden nexus between former promoters and corporate entities like RHT Health Trust, evaluate lender conduct, and ensure an adequate inflow and unmasking of money to fully satisfy Daiichi Sankyo’s multi-billion-dollar arbitration award.